Neuronex

Neuronex

Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€5—8m (Dealroom.co estimates Oct 2010.)
Morrisville North Carolina (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$1.5m

Series A
N/A

$400k

Debt

N/A

Acquisition
Total Funding€1.4m

Recent News about Neuronex

Edit
More about Neuronexinfo icon
Edit

Neuronex Inc. is a biotechnology company focused on developing and commercializing therapies for a wide range of nervous system disorders. The company serves patients, caregivers, healthcare professionals, and investors, operating primarily in the biopharmaceutical industry. Neuronex Inc. leverages its deep understanding of nervous system research to create life-changing therapies aimed at improving the lives of millions of people. The business model revolves around the research, development, and marketing of innovative treatments, generating revenue through the sale of these therapies. The company maintains an open dialogue with its stakeholders to ensure the effectiveness and accessibility of its products.

Keywords: biotechnology, nervous system, therapies, biopharmaceutical, patients, caregivers, healthcare, research, development, commercialization.